1. Introduction {#sec1}
===============

Nitric oxide has many diverse functions in the mammalian body and is produced in mammals by a family of nitric oxide synthase enzymes (NOS: EC 1.14.13.39) \[[@B1]\]. These enzymes are composed of an N-terminus oxygenase domain containing a heme, tetrahydrobiopterin (H~4~B), and the substrate L-arginine as well as a C-terminus reductase domain. There are over thirty NOS-like proteins in prokaryotes including eight different types reported in *bacilli*\[[@B2]\]. Bacterial NOS-like enzymes lack the associated NOS reductase domain found in mammalian enzymes \[[@B3]\]. The bacterial NOSs have many properties in common with the mammalian oxygenase domain including dimer structure, L-Arginine as a substrate, and typical heme spectroscopy \[[@B2]\]. Very little is known about the function of these proteins in prokaryotes, and they are not required for nitrification and denitrification pathways \[[@B4]\].

The opportunistic pathogen *B. cereus*causes food poisoning and is closely related to the animal and human pathogen *B. anthracis*used as a biological weapon as well as the insect pathogen *B. thuringiensis*that is used as a pesticide. We report the cloning, expression, purification, and characterization of a NOS-like protein from *Bacillus cereus* (bcNOS).

2. Materials and Methods {#sec2}
========================

2.1. Materials {#sec2.1}
--------------

All reagents were purchased from Sigma-Adrich Canada Ltd. (Oakville, ON, Canada) and Fisher-Scientific Ltd. (Ottawa, ON, Canada) and were of high quality chemical grade.

2.2. Molecular Biology {#sec2.2}
----------------------

The bcNOS gene from *B*. *cereus*(ATCC strain number 10987) was amplified by PCR from genomic DNA. The following PCR primers generated an Nde I site (bold) before the 5′ start codon in BCNOSF1 and an EcoR I site (underlined) after the 3′ stop codon in BCNOSR1: BCNOSF1, 5′-GAA GAT CT**C ATA TG**A GTA AAA CGA AGC AAT TAA TAG AGG AAG CG-3′; BCNOSREV, 5′-GG[G AAT TC]{.ul}C TAT TTA TGA AAA AAA TTC GGC TTC AAA ATT TC-3′. The amplified fragment was cloned into the pET28a expression vector (Novagen, Madison, WI), which contains a His~6~coding region upstream from the Nde I site.

2.3. Expression and Purification of Proteins {#sec2.3}
--------------------------------------------

*E. coli* strain BL21(DE3) pLysS transfected with the bcNOS plasmid and grown in Luria-Bertani broth containing 100 *μ*g/mL ampicillin, induced at an OD (600 nm) of 0.6 with 1 mM IPTG and grown for 4 hours and then harvested. The recombinant bcNOS was purified from the bacterial cells using metal chelating chromatography \[[@B5]\] (see Supplementary Material available online at doi: 10.1155/2010/489892). Recombinant rat nNOS reductase protein was overexpressed in *Escherichia coli*strain BL21(DE3) and purified as previously described \[[@B6]\].

2.4. Mass Spectrometry and Chromatography {#sec2.4}
-----------------------------------------

Mass spectrometry of the purified bcNOS was performed at the WATSPEC Mass Spectroscopy Facility at the University of Waterloo \[[@B5]\]. Gel exclusion chromatography was used to estimate the molecular weight of bcNOS dimer \[[@B5]\].

2.5. Spectroscopy {#sec2.5}
-----------------

Spectroscopy performed on a Varian-Cary 1. The bcNOS exhibited a typical heme peak around 400 nm. Enzyme (10 *μ*M) was incubated in the presence of 1 mM imidazole, 1 mM L-arginine, 100 *μ*M H~4~B, or CO gas. Difference spectroscopy was used to measure the binding affinities of imidazole, NOHA, and L-arginine as previously described \[[@B7]\].

2.6. Catalytic Activity Assays {#sec2.6}
------------------------------

The H~2~O~2~-dependent bcNOS oxidation of NOHA and L-arginine to nitrite was monitored at 25°C on a 96-well plate reader as presiously reported \[[@B8], [@B9]\]. The hemoglobin capture assay \[[@B10]\] was used to monitor nitric oxide production from bcNOS in the presence of L-arginine and the rat neuronal NOS reductase domain.

3. Results and Discussion {#sec3}
=========================

The sequence alignment of the bcNOS protein with the NOS-like proteins from *B. subtilis*(bsNOS), *Staphylococcus aureus*(saNOS), and *D. radiodurans*(deiNOS) revealed a 42 to 52% identity and 61 to 68% conservation of the sequence and full conservation of the residues involved in binding to the heme (see Figure 1 in supplementary materials). A comparison of the bcNOS protein with the human inducible NOS (iNOS) revealed a 40% identity and 57% conservation of the sequence. Recombinant bcNOS was purified to greater than 90% homogeneity based upon SDS-PAGE and mass spectrometry analysis (see Figure 2 in supplementary materials). A yield of 8 mg of pure bcNOS was obtained per liter of culture. Nondenaturing native-PAGE and gel exclusion chromatography both showed that bcNOS forms a dimer.

The bcNOS UV-visible spectrum showed the presence of a heme chromophore in a high spin state ([Figure 1](#fig1){ref-type="fig"}). The observed spectral changes of bcNOS due to the binding of different heme ligands are summarized in [Table 1](#tab1){ref-type="table"}. The characteristic Soret absorbance peak of 399 nm was observed for ferric bcNOS ([Figure 1](#fig1){ref-type="fig"}), likely corresponding to a mixture of 5-coordinated high-spin species and a water-bound 6-coordinated low-spin species. The binding of DDT shifts the equilibrium towards a fully 5-coordinated high-spin species. When H~4~B was added the Soret peak shifted to 397 nm. The slight blue shift in the spectrum indicates that the H~4~B displaced the DTT ligand. Adding L-arginine produced the same result as H~4~B, resulting in a Soret absorbance peak shift to 397 nm. The addition of imidazole resulted in a low-spin heme state with a peak absorbance of 426 nm that is typical of imidazole serving as a distal sixth ligand in the active site of NOS enzymes. Dithionite-reduced, carbon monoxide (CO) bound bcNOS gave absorbance peaks at 443 nm and 545 nm, comparable to the mammalian iNOS and neuronal NOS (nNOS) oxygenase domains and other bacterial NOS-like proteins ([Table 1](#tab1){ref-type="table"}) indicating a similar heme iron coordination structure.

Difference spectrometry, used to study heme-substrate interactions, revealed that a substrate-binding site exists in bcNOS close to the heme group and that this site is capable of binding imidazole, NOHA, or L-arginine. The displacement of heme-bound imidazole due to the binding of NOHA or L-arginine was monitored to determine the binding affinity of NOHA and L-arginine to bcNOS. Double-reciprocal analysis of the binding of imidazole to bcNOS gave a *K* ~*d*~ value of 181 ± 13 *μ*M. The binding affinities of NOHA and L-arginine were much greater with *K* ~*s*~ values of 1.12 ± 0.01 and 11 ± 3, respectively. The apparent binding affinity of L-arginine to bcNOS was found to be similar to those determined for other bacterial NOS proteins and the mammalian iNOSoxy protein ([Table 2](#tab2){ref-type="table"}). This is consistent with bcNOS containing a conserved glutamate residue found to be essential for high affinity L-arginine binding in mammalian NOS enzymes \[[@B19]\].

Tetrahydrobiopterin-free nNOS can oxidize NOHA or L-arginine to nitrite in the presence of H~2~O~2~ \[[@B13]\]. Despite low binding constants for both NOHA and L-arginine, low levels of activity were found for the bcNOS protein in the presence of H~2~O~2~ and either NOHA (0.100 ± 0.014 min^−1^) or L-arginine (0.048 ± 0.001 minute). When compared to mammalian NOS enzymes, slow turnover numbers for H~2~O~2~-supported NOHA oxidation have also been reported for other bacterial NOS-like proteins \[[@B11], [@B20], [@B21]\]. The addition of H~4~B did not significantly increase the activity of bcNOS, but in the presence of NOHA and THF the activity doubled (0.231 ± 0.023). This suggests that a biological ligand, such as THF or a related pterin, may be required by bcNOS for catalytic activity. A similar catalytic rate was determined for saNOS in the absence of a cofactor (0.15 ± 0.01 nmol nitrite min^−1^nmol saNOS) with no increase in activity observed in the presence of THF \[[@B14]\] and a recent report indicates that THF may replace H~4~B as a redox-active cofactor in deiNOS \[[@B20]\].

The bcNOS protein was not catalytically active when coupled with the rat nNOS reductase domain protein in the presence of L-arginine and NADPH despite the fact that the nNOS reductase domain protein readily transfers electrons to reduce cytochrome *c*\[[@B6]\]. The relevance of such a reconstituted system comes into question, as a reductase protein similar to the mammalian NOS reductase domain could not be found in the *B. cereus*genome. Bacterial flavodoxins have been reported to support nitric oxide production by *B. subtilis* nitric oxide synthase \[[@B21]\]. We were unable to identify the electron donor(s) of bcNOS which is consistent with a recent report showing that bacterial NOS proteins do not appear to accept electrons from a specific reductase but more likely accept electrons from several different sources \[[@B15]\].

The NO produced by bacterial NOS enzymes has been associated with a number of novel functions. In *Streptomyces*NOS mediates the nitration of the tryptophan moiety of the phytotoxin dipeptide L-tryptophan-L-phenylalanine \[[@B16]\]. Disruption of the NOS gene in *B. subtilis* renders the strain more susceptible to oxidative damage \[[@B17]\]. Our *B. cereus nos*gene knock out strain was also found to be more vulnerable to hydrogen peroxide exposure (results not shown). Notably, *B. anthracis*derived-NO is correlated with pathogen virulence and survival in macrophages \[[@B18]\]. Clearly, there are several unanswered questions regarding bacterial NOS enzymes including cofactor requirements, evolutionary traits, catalytic mechanism, their biological reductase partners, and their in vivo function(s).

Supplementary Material {#supplementary-material-sec}
======================

###### 

The supplementary material includes sequence alignments of bacterial NOS-like proteins and three mammalian NOS oxygenase domains. The results of our complete characterization of the the *Bacillus cereus* NOS-like protein are also included in the supplementary section.

###### 

Click here for additional data file.
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*ba:*

:   *Bacillus anthracis*

*bs:*

:   *Bacillus subtilis*

dei:

:   *D. radiodurans*

H~4~B:

:   (6R)-5,6,7,8-tetrahydrobiopterin

NOHA:

:   N^G^-hydroxy-L-arginine

NOS:

:   Nitric oxide synthase

NOS~oxy~:

:   Oxygenase domain of NOS

Sa:

:   *Staphylococcus aureus*

THF:

:   Yetrahydrofolate.

![Spectral graphs of bcNOS with heme bind ligands. The UV-visible spectrum of bcNOS (---) protein was performed as stated in the Materials and Methods. Protein was incubated in the presence of H~4~B (- ^.\ .^ -), L-arginine (- - -), imidazole (- ^.^ -), and CO (^.\ .\ .\ .^).](BCRI2010-489892.001){#fig1}

###### 

Soret and visible spectral properties (wavelength (nm) at peak absorbance) of bcNOS, deiNOS, bsNOS, nNOSoxy, and iNOSoxy with L-arginine and other various heme ligands.

  Enzyme-ligand complex   bcNOS   deiNOS^a^   bsNOS^b^   nNOSoxy^a^   iNOSoxy^b^                     
  ----------------------- ------- ----------- ---------- ------------ ------------ ---------- ------ ----------
  Ferric enzyme           399     650         N.D.       N.D.         402          N.D.       N.D.   418
  \+ H~4~B                397     650         N.D.       N.D.         399          N.D.       N.D.   400
  \+ L-Arg                397     645         393        650          398          393        650    401
  \+ L-Arg + H~4~B        395     643         N.D.       N.D.         395          N.D.       N.D.   396
  \+ Imidazole            426     547         427        550          426          427        550    427
  \+ Dithiothreitol       399     650         380, 460   650          400          380, 460   650    375, 459
  Ferrous-CO              443     545         444        540          445          444        540    444

^a^taken from \[[@B11]\]. ^b^taken from \[[@B12]\]. N.D.: not determined. nNOSoxy: neuronal NOS oxygenase domain. iNOSoxy: inducible NOS oxygenase domain.

###### 

Comparison of the binding properties of bcNOS to other bacterial NOS-like and mammalian NOS oxygenase domain proteins.

  Binding constants (*μ*M)   bcNOS         bsNOS^a^    deiNOS^b^   iNOSoxy^a^   nNOSoxy^b^
  -------------------------- ------------- ----------- ----------- ------------ ------------
  *K* ~*d*~ imidazole        181 ± 13      384 ± 10    ---         158 ± 6      ---
  *K* ~obs~ L-Arg            596 ± 161     129 ± 2     97 ± 10     175 ± 4      55 ± 4
  *K* ~s~ L-Arg              11 ± 3        4.8 ± 0.1   ---         16.1 ± 0.7   ---
  *K* ~s~ NOHA               1.12 ± 0.01   ---         ---         ---          ---

^a^taken from \[[@B8]\]. ^b^taken from \[[@B11]\]. iNOSoxy: inducible NOS oxygenase domain. nNOSoxy: neuronal NOS oxygenase domain.
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